BioSante Pharma Gets Two Patents For Protein Manufacturing
The first issued US patent, US Pat No, 7,632,059, covers methods for manufacturing recombinant antibodies. By incorporating 2A/Furin technology into antibody-expression in viral vectors it is possible to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.